Related Experiment Videos
Molecular confirmation of Ewing sarcoma
R Dagher1, T A Pham, L Sorbara
1Pediatric Oncology Branch , National Cancer Institute. National Institutes of Health, Bethesda, Maryland 20892, USA.
Journal of Pediatric Hematology/Oncology
|February 16, 2002
Summary
Reverse transcription polymerase chain reaction (RT-PCR) testing is crucial for diagnosing Ewing sarcoma and related tumors. Optimizing sample quality and biopsy techniques improves molecular marker assessment and diagnostic accuracy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing sarcoma and primitive neuroectodermal tumors (PNET) are aggressive cancers requiring accurate molecular diagnosis.
- Reverse transcription polymerase chain reaction (RT-PCR) is a key technique for detecting characteristic translocations in these tumors.
Purpose of the Study:
- To retrospectively analyze RT-PCR results and demographic data in patients with suspected Ewing sarcoma/PNET.
- To identify factors influencing molecular marker status determination.
Main Methods:
- Retrospective analysis of tumor samples from 76 patients diagnosed with Ewing sarcoma/PNET.
- Histopathologic review and RT-PCR testing for translocations (EWS-FLI, EWS-ERG).
- Evaluation of biopsy methods and sample quality.
Main Results:
- RT-PCR confirmed translocations in 58 patients, including EWS-FLI and EWS-ERG types.
- Nested RT-PCR identified translocations in four additional cases.
- Inadequate samples or alternative diagnoses were noted in 18 translocation-negative cases.
Conclusions:
- Translocation-negative cases warrant investigation for alternative diagnoses, need for nested RT-PCR, or inadequate samples.
- Open biopsy is recommended over needle biopsy to improve diagnostic accuracy and avoid repeat procedures.